drugset / Trial / NCT00287391

Sleep Disorders and Gastroesophageal Reflux Disease (GERD)

NCT00287391

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will investigate Gastroesophageal Reflux Disease (GERD)as a cause of sleep disturbance. Patients with GERD may experience all or some of the following symptoms: stomach acid or partially digested food re-entering the esophagus (which is sometimes referred to as heartburn or regurgitation) and belching. Even very small, unnoticeable amounts of rising stomach acid may cause patients to wake up during the night. This study will also investigate the effect of Rabeprazole, (brand name Aciphex) on patients with known insomnia. Rabeprazole is an FDA approved medication already marketed for the treatment of GERD.

Timeline

Start
2004-09
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 20 mg